help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by POUW, E. M.
Right arrow Articles by WOUTERS, E. F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by POUW, E. M.
Right arrow Articles by WOUTERS, E. F. M.

Am. J. Respir. Crit. Care Med., Volume 158, Number 3, September 1998, 797-801

Plasma and Muscle Amino Acid Levels in Relation to Resting Energy Expenditure and Inflammation in Stable Chronic Obstructive Pulmonary Disease

ELLEN M. POUW, ANNEMIE M. W. J. SCHOLS, NICOLAAS E. P. DEUTZ, and EMIEL F. M. WOUTERS

Departments of Pulmonology and Surgery, Maastricht University, Maastricht; and Asthmacentre Hornerheide, Horn, The Netherlands

In patients with chronic obstructive pulmonary disease (COPD), muscle wasting can occur independently of fat loss, suggesting disturbances in protein metabolism. In order to provide more insight in amino-acid (AA) metabolism in patients with stable COPD, we examined arterial plasma and anterior tibialis muscle AA levels, comparing 12 COPD patients with eight age-matched healthy control subjects. We also studied relationships between AA levels, the acute phase response as measured by lipopolysaccharide-binding protein (LBP), and resting energy expenditure (REE). In contrast to findings in acute diseases associated with muscle wasting, we found increased muscle glutamine (GLN) levels in our patient group (mean ± SEM = 10,782 ± 770 versus 7,844 ± 293 µmol/kg wet weight, p < 0.01). Furthermore, muscle arginine, ornithine, and citrulline were significantly increased in the patient group, whereas glutamic acid was decreased. In plasma, the sum of all AA (SumAA) was decreased in the patient group (2,595 ± 65 versus 2,894 ± 66 µmol/L, p < 0.01), largely because of decreased levels of alanine (254 ± 10 versus 375 ± 25 µmol/L, p < 0.0001), GLN (580 ± 17 versus 641 ± 17 µmol/L, p < 0.05), and glutamic acid (91 ± 5 versus 130 ± 10 µmol/L, p < 0.01). LBP levels were increased in COPD patients as compared with controls (11.7 ± 4.5 versus 8.6 ± 1.0 mg/L, p < 0.05), and showed a positive correlation with REE (r = 0.49, p = 0.03), a negative correlation with the SumAA in plasma (r = -0.76, p < 0.0001), and no correlation with muscle AA levels. In conclusion, various disturbances in plasma and muscle AA levels were found in COPD patients. A relationship between the observed decreased plasma AA levels and inflammation was suggested.




This article has been cited by other articles:


Home page
 Am. J. Clin. Nutr.Home page
E. P. Rutten, F. M. Franssen, M. P. Engelen, E. F. Wouters, N. E. Deutz, and A. M. Schols
Greater whole-body myofibrillar protein breakdown in cachectic patients with chronic obstructive pulmonary disease.
Am. J. Clinical Nutrition, April 1, 2006; 83(4): 829 - 834.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
E. P. Rutten, M. P. Engelen, E. F. Wouters, A. M. Schols, and N. E. Deutz
Metabolic effects of glutamine and glutamate ingestion in healthy subjects and in persons with chronic obstructive pulmonary disease
Am. J. Clinical Nutrition, January 1, 2006; 83(1): 115 - 123.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
A. G. N. Agusti
Systemic Effects of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, November 1, 2005; 2(4): 367 - 370.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. Couillard and C. Prefaut
From muscle disuse to myopathy in COPD: potential contribution of oxidative stress
Eur. Respir. J., October 1, 2005; 26(4): 703 - 719.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
E. P. A. Rutten, M. P.K.J. Engelen, C. L. N. Castro, E. F. M. Wouters, A. M.W.J. Schols, and N. E. P. Deutz
Decreased Whole-Body and Splanchnic Glutamate Metabolism in Healthy Elderly Men and Patients with Chronic Obstructive Pulmonary Disease in the Postabsorptive State and in Response to Feeding
J. Nutr., September 1, 2005; 135(9): 2166 - 2170.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. Troosters, R. Casaburi, R. Gosselink, and M. Decramer
Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., July 1, 2005; 172(1): 19 - 38.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
C. E. Bolton, A. A. Ionescu, K. M. Shiels, R. J. Pettit, P. H. Edwards, M. D. Stone, L. S. Nixon, W. D. Evans, T. L. Griffiths, and D. J. Shale
Associated Loss of Fat-free Mass and Bone Mineral Density in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., December 15, 2004; 170(12): 1286 - 1293.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M.P.K.J. Engelen, M. Orozco-Levi, N.E.P. Deutz, E. Barreiro, N. Hernandez, E.F.M. Wouters, J. Gea, and A.M.W.J. Schols
Glutathione and glutamate levels in the diaphragm of patients with chronic obstructive pulmonary disease
Eur. Respir. J., April 1, 2004; 23(4): 545 - 551.
[Abstract] [Full Text] [PDF]

Home page
 J ANIM SCIHome page
D. Melchior, B. Seve, and N. Le Floc'h
Chronic lung inflammation affects plasma amino acid concentrations in pigs
J Anim Sci, April 1, 2004; 82(4): 1091 - 1099.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
R.T. Jagoe and M.P.K.J. Engelen
Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease
Eur. Respir. J., November 2, 2003; 22(46_suppl): 52S - 63s.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A.M.W.J. Schols
Nutritional and metabolic modulation in chronic obstructive pulmonary disease management
Eur. Respir. J., November 2, 2003; 22(46_suppl): 81S - 86s.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
E. Gamble, D. C. Grootendorst, C. E. Brightling, S. Troy, Y. Qiu, J. Zhu, D. Parker, D. Matin, S. Majumdar, A. M. Vignola, et al.
Antiinflammatory Effects of the Phosphodiesterase-4 Inhibitor Cilomilast (Ariflo) in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., October 15, 2003; 168(8): 976 - 982.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
E F M Wouters
Chronic obstructive pulmonary disease * 5: Systemic effects of COPD
Thorax, December 1, 2002; 57(12): 1067 - 1070.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. Marquis, R. Debigare, Y. Lacasse, P. LeBlanc, J. Jobin, G. Carrier, and F. Maltais
Midthigh Muscle Cross-Sectional Area Is a Better Predictor of Mortality than Body Mass Index in Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., September 15, 2002; 166(6): 809 - 813.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. P. K. J. ENGELEN, E. F. M. WOUTERS, N. E. P. DEUTZ, J. D. DOES, and A. M. W. J. SCHOLS
Effects of Exercise on Amino Acid Metabolism in Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., March 15, 2001; 163(4): 859 - 864.
[Abstract] [Full Text]

Home page
 Am. J. Clin. Nutr.Home page
M. P. Engelen, E. F. Wouters, N. E. Deutz, P. P. Menheere, and A. M. Schols
Factors contributing to alterations in skeletal muscle and plasma amino acid profiles in patients with chronic obstructive pulmonary disease
Am. J. Clinical Nutrition, December 1, 2000; 72(6): 1480 - 1487.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. P. K. J. ENGELEN, A. M. W. J. SCHOLS, J. D. DOES, H. R. GOSKER, N. E. P. DEUTZ, and E. F. M. WOUTERS
Exercise-Induced Lactate Increase in Relation to Muscle Substrates in Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1697 - 1704.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. P. K. J. ENGELEN, N. E. P. DEUTZ, E. F. M. WOUTERS, and A. M. W. J. SCHOLS
Enhanced Levels of Whole-body Protein Turnover in Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1488 - 1492.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
S. R Thomas, A. Ray, M. E Hodson, and T. L Pitt
Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease
Thorax, September 1, 2000; 55(9): 795 - 797.
[Abstract] [Full Text]

Home page
 Am. J. Clin. Nutr.Home page
H. R Gosker, E. F. Wouters, G. J van der Vusse, and A. M. Schols
Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives
Am. J. Clinical Nutrition, May 1, 2000; 71(5): 1033 - 1047.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
E. F.M. Wouters
Nutrition and Metabolism in COPD
Chest, May 1, 2000; 117(5_suppl_1): 274S - 280S.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1998 American Thoracic Society